We’re pleased to announce a virtual “office hour” for people interested in applying for our Initiative for Maximizing Student Development (IMSD) and Graduate Research Training Initiative for Student Enhancement (G-RISE) programs. The next application due date for both programs is January 30, 2023.
These research training programs share the goal of developing a diverse pool of scientists earning a biomedical Ph.D., but have different institutional eligibility based on NIH research project grant (RPG) support. IMSD eligibility is limited to research-intensive institutions (i.e., those with an average of funding greater than or equal to $7.5 million total costs over the last 3 fiscal years) while G-RISE eligibility is limited to research-active institutions (i.e., those with an average of NIH RPG funding less than $7.5 million total costs over the last 3 fiscal years).
During the meeting, we’ll provide a brief overview of the IMSD and G-RISE funding opportunity announcements (FOAs) and answer your programmatic, budget, and scientific review questions. Those interested in joining the office hour are strongly encouraged to review the 2021 IMSD/G-RISE webinar and companion slide deck [PDF] prior to the meeting.
Office Hour Information:
Tuesday, December 13, 4:00-5:00 p.m. ET
Zoom meeting link
Meeting ID: 161 398 3851
Join by phone: 669-254-5252 (San Jose) or 646-828-7666 (New York)
Participants requiring sign language interpretation and/or other reasonable accommodations should submit a request using our contact form at least 5 days prior to the meeting. Note this is a live event that will not be recorded.
NIGMS Staff Participating in the December 13th Office Hour:
- Shakira Nelson, IMSD Program Officer
- Mercedes Rubio, IMSD Program Officer
- Sydella Blatch, G-RISE Program Officer
- Justin Rosenzweig, NIGMS Grants Management Officer
- Latarsha Carithers, NIGMS Scientific Review Officer
If you have any questions about the office hour, please contact Shakira Nelson or Mercedes Rubio for IMSD and Sydella Blatch for G-RISE.